☰

Rebecca T. Marquez, Ph.D. - Publications

Affiliations: 
2009 Molecular & Cell Biology University of Iowa, Iowa City, IA 
Area:
Cell Biology, Virology Biology
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Lan L, Liu H, Smith AR, Appelman C, Yu J, Larsen S, Marquez RT, Wu X, Liu FY, Gao P, Gowthaman R, Karanicolas J, De Guzman RN, Rogers S, Aubé J, et al. Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins. Bmc Cancer. 18: 809. PMID 30097032 DOI: 10.1186/S12885-018-4704-Z  0.324
2018 Li J, Smith AR, Marquez RT, Li J, Li K, Lan L, Wu X, Zhao L, Ren F, Wang Y, Wang Y, Jia B, Xu L, Chang Z. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression. Molecular Carcinogenesis. PMID 29938829 DOI: 10.1002/Mc.22866  0.533
2017 Wu X, Marquez R, Han S, Lan L, Dixon DA, Aubé J, Welch DR, Xu L. Abstract 1145: Overcoming chemoresistance and blocking metastasis in breast cancer by targeting HuR Cancer Research. 77: 1145-1145. DOI: 10.1158/1538-7445.Am2017-1145  0.309
2016 Wu X, Tang W, Marquez RT, Li K, Highfill CA, He F, Lian J, Lin J, Fuchs JR, Ji M, Li L, Xu L. Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. Oncotarget. PMID 26887043 DOI: 10.18632/Oncotarget.7336  0.349
2016 Han S, Wu X, Guo Y, Zhang J, Gu X, Marquez RT, Aube J, Xu L. Abstract 5162: Id1 is an oncogenic target of RNA binding protein HuR in gastric cancer Cancer Research. 76: 5162-5162. DOI: 10.1158/1538-7445.Am2016-5162  0.349
2016 Wu X, Marquez RT, Han S, Li K, Lan L, Guo Y, Dixon DA, Aubé J, Welch DR, Xu L. Abstract 4832: Overcoming breast cancer chemoresistance and blocking metastasis by targeting RNA-binding protein HuR Cancer Research. 76: 4832-4832. DOI: 10.1158/1538-7445.Am2016-4832  0.352
2016 Lan L, Liu H, Smith A, Appelman C, Yu J, Larsen S, Marquez R, Wu X, Gao P, Gowthaman R, Karanicolas J, Guzman RD, Rogers S, Aubé J, Neufeld K, et al. Abstract 4817: Molecular cancer therapy targeting RNA-binding protein Musashi-1 Cancer Research. 76: 4817-4817. DOI: 10.1158/1538-7445.Am2016-4817  0.324
2016 Marquez RT, Xu L. Abstract 4193: Reporter systems to measure dynamics and specificity of targeted cancer therapy Cancer Research. 76: 4193-4193. DOI: 10.1158/1538-7445.Am2016-4193  0.383
2015 Yang H, Das P, Yu Y, Mao W, Wang Y, Baggerly K, Wang Y, Marquez RT, Bedi A, Liu J, Fishman D, Lu Z, Bast RC. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms. Oncotarget. PMID 26689988 DOI: 10.18632/Oncotarget.6576  0.367
2015 Smith AR, Marquez RT, Tsao WC, Pathak S, Roy A, Ping J, Wilkerson B, Lan L, Meng W, Neufeld KL, Sun XF, Xu L. Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression. Oncotarget. 6: 12558-73. PMID 25940441 DOI: 10.18632/Oncotarget.3726  0.544
2015 Lan L, Appelman C, Smith AR, Yu J, Larsen S, Marquez RT, Liu H, Wu X, Gao P, Roy A, Anbanandam A, Gowthaman R, Karanicolas J, De Guzman RN, Rogers S, et al. Natural product (-)-gossypol inhibits colon cancer cell growth by targeting RNA-binding protein Musashi-1. Molecular Oncology. PMID 25933687 DOI: 10.1016/J.Molonc.2015.03.014  0.378
2015 Carlson EA, Marquez RT, Du F, Wang Y, Xu L, Yan SS. Overexpression of 17β-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death. Bmc Cancer. 15: 166. PMID 25879199 DOI: 10.1186/S12885-015-1173-5  0.337
2015 Wu X, Lan L, Wilson DM, Marquez RT, Tsao WC, Gao P, Roy A, Turner BA, McDonald P, Tunge JA, Rogers SA, Dixon DA, Aubé J, Xu L. Identification and Validation of Novel Small Molecule Disruptors of HuR-mRNA Interaction. Acs Chemical Biology. 10: 1476-84. PMID 25750985 DOI: 10.1021/Cb500851U  0.358
2015 Lan L, Appelman C, Smith A, Yu J, Larsen S, Marquez R, Wu X, Liu H, Roy A, Anbanandam A, Gowthaman R, Karanicolas J, Rogers S, Aubé J, Guzman RD, et al. Abstract 5427: Small molecule inhibitors of Musashi family of RNA-binding proteins Cancer Research. 75: 5427-5427. DOI: 10.1158/1538-7445.Am2015-5427  0.34
2015 Yang H, Das P, Mao W, Marquez RT, Lu Z, Bast RC. Abstract 5105: The imprinted tumor suppressor gene NDN inhibits cell motility in ovarian cancer by reactivating FAK and RhoA Cancer Research. 75: 5105-5105. DOI: 10.1158/1538-7445.Am2015-5105  0.34
2015 Smith AR, Marquez R, Tsao B, Roy A, Wilkerson B, Pathak S, Neufeld K, Sun X, Xu L. Abstract 3127: Small but lethal, miR-137 acts as a tumor suppressive microRNA in colorectal cancer Cancer Research. 75: 3127-3127. DOI: 10.1158/1538-7445.Am2015-3127  0.496
2015 Wu X, Lan L, Smith A, Marquez R, Wilson D, Rogers S, Gao P, Lovell S, Karanicolas J, Dixon D, Aubé J, Xu L. Abstract 2449: Targeting an “undruggable” RNA-binding protein: Discovery of small molecule inhibitors of HuR for novel breast cancer therapy Cancer Research. 75: 2449-2449. DOI: 10.1158/1538-7445.Am2015-2449  0.376
2014 Marquez RT, Smith AR, Tsao B, Xu L. Abstract 5240: Epigenetic dysregulation of miR-196b in breast cancer Cancer Research. 74: 5240-5240. DOI: 10.1158/1538-7445.Am2014-5240  0.507
2014 Yang H, Das P, Yu Y, Baggerly K, Wang Y, Mao W, Marquez RT, Lu Z, Liu J, Bast RC. Abstract 2311: NDN, an imprinted tumor suppressor gene inhibits ovarian cancer cell growth and motility and is downregulated by genetic and epigenetic mechanisms Cancer Research. 74: 2311-2311. DOI: 10.1158/1538-7445.Am2014-2311  0.375
2014 Smith AR, Marquez R, Tsao B, Lan L, Pathak S, Sun X, Neufeld K, Xu L. Abstract 1460: Tumor suppressor miR-137 inhibits colorectal cancer progression by negatively regulating cancer stem cell marker, Musashi-1 Cancer Research. 74: 1460-1460. DOI: 10.1158/1538-7445.Am2014-1460  0.549
2012 Meng X, Marquez R, Smith A, Balcomb B, Highfill C, Tang W, Xu L. Abstract 5692: Targeted inhibition of cancer stem cells by self-assembled miRNA-nanovectors Cancer Research. 72: 5692-5692. DOI: 10.1158/1538-7445.Am2012-5692  0.375
2012 Yang H, Das PM, Lu Z, Yu Y, Marquez RT, Liao W, Bast RC. Abstract 2182: Epigenetic regulation and growth suppression by NDN, an imprinted tumor suppressor gene whose expression is decreased in epithelial ovarian cancers Cancer Research. 72: 2182-2182. DOI: 10.1158/1538-7445.Am2012-2182  0.376
2011 Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, McCaffrey AP. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. The Journal of Infectious Diseases. 203: 1753-62. PMID 21606534 DOI: 10.1093/Infdis/Jir186  0.676
2010 Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Laboratory Investigation; a Journal of Technical Methods and Pathology. 90: 1727-36. PMID 20625373 DOI: 10.1038/Labinvest.2010.126  0.679
2010 Marquez RT, Wendlandt E, Galle CS, Keck K, McCaffrey AP. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. American Journal of Physiology. Gastrointestinal and Liver Physiology. 298: G535-41. PMID 20167875 DOI: 10.1152/Ajpgi.00338.2009  0.674
2008 Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 112: 1489-502. PMID 18286529 DOI: 10.1002/Cncr.23323  0.335
2008 Marquez RT, McCaffrey AP. Advances in microRNAs: implications for gene therapists. Human Gene Therapy. 19: 27-38. PMID 18092919 DOI: 10.1089/Hum.2007.147  0.625
2005 Marquez RT, Baggerly KA, Patterson AP, Liu J, Broaddus R, Frumovitz M, Atkinson EN, Smith DI, Hartmann L, Fishman D, Berchuck A, Whitaker R, Gershenson DM, Mills GB, Bast RC, et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6116-26. PMID 16144910 DOI: 10.1158/1078-0432.Ccr-04-2509  0.324
2004 Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3291-300. PMID 15161682 DOI: 10.1158/1078-0432.Ccr-03-0409  0.304
2004 Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC. A genetically defined model for human ovarian cancer. Cancer Research. 64: 1655-63. PMID 14996724 DOI: 10.1158/0008-5472.Can-03-3380  0.339
Show low-probability matches.